Skip to content
EntityQ137049482· pop 9· linked from 2 articles

Also known as AUT00063

AUT00063 (also called AUT-00063) is an investigational small-molecule compound developed by Autifony Therapeutics for hearing loss and tinnitus.

~2 min read

Encyclopedic overview

6 sections
Contents
  • Background and development
  • Clinical trials
  • Tinnitus (QUIET-1)
  • Mechanism of action
  • See also
  • References

AUT00063 (also called AUT-00063) is an investigational small-molecule compound developed by Autifony Therapeutics for hearing loss and tinnitus.

== Background and development ==

Excerpted from Wikipedia’s “AUT-00063” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0